Zhou’s Hypoxicology Therapy (ZHT) was pioneered/developed by Dr. Jin Zhou, DC, in late 2004. It is a new medical clinical concept of etiology, pathophysiology and clinical therapy, which identifies Trachea Caudal Displacement (TCD) & Vocal Cord dysfunction (VCD) induced chronic intermittent hypoxia through Silent Upper Airway Resistance Syndrome (SUARS) and Frequent & Recurrent Upper Airway Collapse Syndrome (FRUACS) or sleep-disordered breathing, as well as nocturnal gastroesophageal reflux (NGER) as a new fundamental physio-pathological mechanism, as one of the main causes, for mild to moderate but prolonged hypoxia for most illness & diseases for worldwide mortality and disability, from pain & arthritis, heart attack, hypertension, diabetes, anxiety & depression to almost every illness & diseases.

Comparison Study with Watch_Pat 100 after one week treatment with ZHT

Subject One

Subject Two

It is now reasonably well-known and established that sleep apnea has been linked to most of the CDC's top 10 death-cause medical conditions, such as heart attack, cancer, stroke and diabetes. However, the original or ultimate cause for sleep apnea is not clearly known at all to the scientists and health care practitioners. Dr. Jin Zhou challenges the popular or mainstream theory in etiology for the sleep apnea that obstruction or collapse of the upper airway is due to the weakened and enlarged soft palate. As a matter of fact, as Dr. Jin Zhou hypothesized, the clinical reality is the exact opposite or completely different, therefore the current mainstream clinical treatment protocols by surgery and CPAP or oral devices are not expected to ultimately cure sleep apnea but simply to provide for some limited or short-term relief or temporarily cover up the deterioration of sleep apnea development.

In developing the new ZHT (Zhou's Hypoxicology Therapy) treatment of sleep apnea, Dr. Zhou, observed clinically that trachea caudal displacement (TCD) (the windpipe moving downward), resulted from diaphragm malfunction and baroreflex dysfunction, instead of weakened soft appellate as claimed by the mainstream scientists, is the main anatomical pathology for snoring, collapse of the upper airway and frequent breathing stops during the night for people with obstructive sleep apnea. In addition, as Dr. Zhou hypothesized, the dysfunction of the baroreflex, chemoreflex, metabo-reflex, mechanoreflex, psychosomato-reflex and respiration pace-making malfunction, due to psychological, environmental and anatomical causations, are primarily and intricately responsible for the obstructive and central sleep apnea development. Dr. Zhou further hypothesized that all of these sleep apnea etiological components are primarily controlled or regulated internally by the human body but induced externally. Therefore, sleep apnea should be completely reversible primarily through volitional resuscitation, resetting of the baroreflex and revitalization of the upper airway defense reflex by working through patient's body internally instead of externally through surgeries and devices.
 

Furthermore, Dr. Jin Zhou proposed a new patho-physiological model of  Hypoxicology, Respiratory Pacemaking Deficiency (RPD), Baroreflexicolgy and Dysautonomia.

Hypoxicology includes intermittent chronic hypoxia due to TCD - Tracheal Caudal Displacement, upper air resistance  or apnea and hyponea;

Respiratory Pace-making Deficiency (RPD) includes Respiration central modulation malfunction, respiration auto-resuscitation failure, CSA (Central Sleep Apnea), apnea/hyponea, SIDS;

Baroreflexicology includes chemoreflex, baroreflex dysfunction or failure due to hypoxia AND respiration pacemaking malfunction or deficiency;

Dysautonomia includes autonomic dysfunction primarily due to chemoreflex,  baroreflex malfunction or failure, and RPD (Respiratory Pace-making Deficiency)  as well as intermittent hypoxia.

More importantly, Dr. Jin Zhou also developed an innovative clinical therapy, ZHT (Zhou’s Hypoxicology Therapy) to prevent, alleviate, and eliminate TCD (Trachea Caudal Displacement), sleep-disordered breathing, and chronic intermittent hypoxia, to enhance or optimize human innate immune functions by employing human upper airway defensive reflexes and volitional resuscitation inherited or observed from auto-resuscitation or spontaneous recovery.

TCD/VCD/Hypoxia Model Includes:

Vocal Cord Dysfunction (VCD)

Psychogenic Vocal Cord Dysfunction
Exertional Vocal Cord Dysfunction
Environmental Vocal Cord Dysfunction
Occupational Vocal Cord Dysfunction
Sleep Apnea/upper airway collapsing

Trachea Subluxation-Deviation & Scoliosis

Upper Airway Length Reduction (steep jaw and chin drop)- Tracheal Caudal Displacement

TCD - Tracheal Caudal Displacement Includes:

Nasal Obstruction
Uvulo-palato-glosso-pharyngeal vertical space reduction (Uvulopalatopharyngeal Stenosis-UPPS)
Diaphragm and Respiratory Muscle Malfunction
Hypoxia and Apnea
Multiple System Malfunction and Dysfunction

GERD

Neuro-Somato-Sensory Deficits (NSSD)

Cortical -  subcortical - laryngeal - pulmonary - Diaphragm- GI Integration Dysfunction with somato-sensory deficits, to include baroreflex -  chemoreflex - sympathetic outflow - dysfunctions of respiratory pacemaker (CSA) and circulatory pacemaker (heart attack & stroke), immuno-metabolic crisis - MSA (Multiple System Atrophy).

TCD/VCD Hypoxia Model mainly includes upper airway obstruction and neuro-sensory deficits, central apnea, diaphragm dystonia and GERD, and many more factors.

ZHT- Zhou's Hypoxicolgy Therapy:  Maximally establishing or opening Upper Airway (Vocal Cord, Entire Trachea) by reversal of TCD - trachea caudal displacement, and maximizing respiration through volitional & auto-vital functional re-setting AND resuscitation, optimizing baroreflex -  chemoreflex - sympathetic outflow and re-setting respiratory ventilation and O2 perfusion through body’s own physiological functions - volitional resuscitation, re-configuration of respiratory pacemaker, with volitional system and upper airway defense reflexes, such as breathing, swallowing and cough augmentation.

Because ZHT is a procedure based on trachea caudal displacement (TCD) and hypoxia-related neuroreflex, chemoreflex-baroreflex, immunoreflex, metabolic system resetting and reconfiguration as well as volitional resuscitation of body basic and vital functions, its application is very broad, it is not mainly developed to fight only symptoms or diagnoses, it is designed to improve and optimize body's own respiration and basic but vital physiological functions.

ZHT is an non-surgical, non-pharmaceutical and manual therapy that can be used to benefit most clinical conditions.

Although this new ZHT ("Zhou's Hypoxicology Therapy") is NOT for severe hypoxia, through opening up upper airway and eliminating upper airway obstruction or resistance and employing upper airway defensive reflexes, it provides the most powerful and fast relief for mild hypoxia, the most mysterious cause for your illness, and hypoxia has been called as "Hidden Killer" by FAA. ZHT, used in conjunction with your conventional and standard therapies, can provide unprecedented clinical results.

ZHT is not recommended or used to replace, delay, interfere with your standard medical care, any medical or healthcare practitioner is advised to follow your applicable state laws and professional standards as well as standards of medical care in you community.